RenovoRx Inc
Stock Chart, Company Information, and Scan Results
$0.90(as of Jan 28, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
RenovoRx Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$0.90
Ticker SymbolRNXT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees10
CountyUSA
Market Cap$33.0M
EBIDTA-11.4M
P/E Ratio-2.97
Forward P/E Ratio0.00
Earnings per Share-0.36
Profit Margin-1,094.74%
RSI42.11
Shares Outstanding36.6M
ATR0.08
52-Week High1.50
Volume146,382
52-Week Low0.70
Book Value8.1M
P/B Ratio4.09
Upper Keltner1.17
P/S Ratio35.58
Lower Keltner0.82
Next Earnings Date04/01/2026
Cash Surplus8.2M
Next Ex-Dividend DateUnknown
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.
RenovoRx Inc In Our Stock Scanner
As of Jan 29, 2026
Scan Name: Bullish Harami PatternScan Type: Candlestick Pattern Scans
As of ---
Scan Name: Inverted Hammer CandleScan Type: Candlestick Pattern Scans
As of ---
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.